Stocks to sell

Clover Health Investments (NASDAQ:CLOV) has finally started to bounce. CLOV stock has climbed about 50% above its lows in recent weeks. Since the stock was over $10 last year, a rally from $2 to just over $3 is hardly a huge comeback. Still, it’s better than continuing to make new lows. Source: Shutterstock So is

The activist investor who famously bet on the Gamestop (NYSE:GME) short squeeze is now going after Bed, Bath & Beyond (NASDAQ:BBBY). Ryan Cohen turned $76 million of GME stock into $1.9 billion by last August. It was a squeeze built on small traders organized at Reddit’s r/WallStreetBets. Now, he has put $150 million into BBBY

With the market in correction mode and investors abandoning growth stocks in droves due to inflation fears, there are many beaten-down stocks right now, particularly in the tech sector. But history shows what looks like “the sum of all fears” nearly always turns out, in the long run, not to be a very big deal.

Greenwich-based hedge fund Hudson Bay Capital Management was the largest shareholder of Vinco Ventures (NASDAQ:BBIG) as of Dec. 31. It owned the equivalent of 15.13 million shares of BBIG stock. Source: vincoventures.com If you are a limited partner of the hedge fund, you can thank your lucky stars that BBIG only represents a tiny portion

We’re barely through two months of the year, and already 2022 is proving to be a very difficult year for investors. Supercharged inflation, war in Europe, sky-high energy prices, constrained supply chains, a global semiconductor shortage and tightening monetary policy have created a vortex of bad conditions for markets around the world. Stocks to sell

Block, Inc. (NYSE:SQ), which used to be called Square, has now closed the acquisition of AfterPay, the Buy Now Pay Later (BNPL) Australian company. The bottom line is that there are better places to put your money than in SQ stock. Source: Sergei Elagin / Shutterstock.com This all-share deal has led to significant stock dilution.

Retail interest in GameStop (NYSE:GME) soared last year after the WallStreetBets Reddit group, whose members numbered in the millions, provoked a speculative buying frenzy. GME stock shot up from less than $20 a share to an all-time high of $483 in just over two weeks as meme-stock mania took hold.  Source: Shutterstock Since that high,

In the wake of Lucid’s (NASDAQ:LCID) fourth-quarter results, reported on Feb. 28, Wall Street and the media seem to be very focused on the reduction in the automaker’s production guidance. Conversely, I’m much more interested in another metric that’s tremendously more important for the long-term outlook of LCID stock: demand. Source: Around the World Photos

AMC Entertainment (NYSE:AMC) has taken investors on a roller-coaster ride of emotions since it burst into the spotlight in early 2021 amid the meme-stock trading frenzy. But with uncertainty in the markets causing investors to adopt a “risk-off” stance, the show may finally be over for AMC stock. Source: Ian Dewar Photography / Shutterstock Since hitting

Lumen Technologies (NYSE:LUMN) stock, formerly known as CenturyLink, is not going to be worth investors’ capital. This is despite recent earnings which provide some reason for optimism. Some investors might want to show Lumen Technologies some optimism and invest their capital.  Source: Postmodern Studio / Shutterstock.com But take a long-term view on this stock and

Easily my least favorite stock to cover, Vinco Ventures (NASDAQ:BBIG) is the bane of my existence. While some companies can be rather obfuscating regarding what they actually do, Vinco really takes the cake. It’s a self-inflicted stun grenade — or flashbang to use special operator parlance — one that leaves BBIG stock staggering in a

Boeing (NYSE:BA) stock effectively symbolizes the strength of U.S. diplomatic influence and its military prowess. However, the thorns of interconnectivity raise big questions for the company. Source: vaalaa / Shutterstock.com As you know, the Biden administration along with western allies have imposed severe sanctions on Russia following its decision to invade Ukraine. Due to the

Does the world really need another electric vehicle (EV) start-up? This is the question which California-headquartered Mullen Automotive (NASDAQ:MULN)  — and really, anyone considering investing in MULN stock — will need to answer. Source: Shutterstock It’s going to be difficult for Mullen to justify its existence, as there are plenty of EV manufacturers already and

BRC Inc. (NYSE:BRCC), which does business as the Black Rifle Coffee Company, recently closed its reverse merger and went public on Feb. 10. BRCC stock shot up from the $10 to $11 range it had been trading at. As of Friday, Mar. 4, it is at $18.60. This puts its valuation in nosebleed territory. Source:

Three years ago, I warned against buying stock in Nio (NYSE:NIO), the Chinese luxury electric vehicle (EV) maker.  At the time, the stock was selling at $6 per share. Source: Robert Way / Shutterstock.com I was wrong. Two years ago, as the Covid-19 pandemic began, China’s government put a floor under the NIO stock price.

Much like its corporate name, sentiment about Block (NYSE:SQ), formerly Square, seems to change at the drop of a hat. Before, the crowd was avoiding SQ stock in droves. Source: Sergei Elagin / Shutterstock.com Partially due to the cycling out of tech, but mostly due to growing bearishness about its prospects, shares in the fintech

Tritium DCFC Limited (NASDAQ:DCFC) is a designer, manufacturer and supplier of current chargers for electric vehicles (EVs) across the globe. The company was incorporated in 2001 and is based in Australia, but it made headlines when it went public by combining with Decarbonization Plus Acquisition Corporation II. In other words, DCFC stock went public via

When it comes to gambling, they say, “the house always wins.” But that hasn’t been the case with DraftKings (NASDAQ:DKNG) and DKNG stock. The i-gaming and online sportsbook operator has captured a large share of the fast-growing U.S. internet gambling market. Source: Tada Images / Shutterstock.com The problem is that it spends around $2.83 on expenses

Embattled theatre chain operator AMC Entertainment (NYSE:AMC) stock has picked up in the past month. A lot had to do with its somewhat encouraging preliminary fourth-quarter results. Source: Helen89 / Shutterstock.com It’s now released its final fourth-quarter earnings results, which are nothing to feel joyful about despite showing progress. AMC stock continues to trade at

Cassava Sciences (NASDAQ:SAVA) is a clinical-stage biotechnology company trying to fight and cure Alzheimer’s disease. Its laudable mission is “to detect and treat Alzheimer’s disease.” The “mission” of SAVA stock, on the other hand, is unclear. Source: Pavel Kapysh / Shutterstock.com Since 2016, this biotechnology company has had no revenue at all. None. This is a